Effect of surgical removal on the growth and kinetics of residual tumor
- PMID: 476622
Effect of surgical removal on the growth and kinetics of residual tumor
Abstract
Findings from this study using a transplantable C3H mammary tumor failed to indicate interaction relative to growth parameters between two foci present in the same host. Whether they were growing alone or in the presence of a second focus, tumor growth rates were similar until the combined mass of multiple tumors approached that which was incompatible with survival. Only then was a difference in growth observed. Cytokinetic parameters, i.e., labeling index, primer-dependent DNA polymerase index or growth fraction, DNA synthesis time, tumor doubling time, and cell cycle time, were also similar whether tumors grew alone or in the presence of a second focus. Following removal of a tumor, changes were observed within 24 hr in the kinetics of the residual focus. There was an increase in labeling index (duration approximately equal to 10 days) and primer-dependent DNA polymerase index with a decrease in the tumor doubling time. Minimal change was noted in DNA synthesis time and cell cycle time. The kinetic changes observed were reflected in a measureable increase in tumor size approximately equal to a week following tumor removal. Absence of an alteration in DNA synthesis time and cell cycle time indicates that the increase in tumor growth was probably due to a conversion of noncycling cells in G0 phase into proliferation. Relationship of the findings to the use of adjuvant chemotherapy is considered.
Similar articles
-
Effect of adriamycin on the cell kinetics of 13762 rat mammary tumors and implications for therapy.Cancer Treat Rep. 1980 Feb-Mar;64(2-3):293-300. Cancer Treat Rep. 1980. PMID: 7407764
-
Influence of the interval between primary tumor removal and chemotherapy on kinetics and growth of metastases.Cancer Res. 1983 Apr;43(4):1488-92. Cancer Res. 1983. PMID: 6831397
-
Presence of a growth-stimulating factor in serum following primary tumor removal in mice.Cancer Res. 1989 Apr 15;49(8):1996-2001. Cancer Res. 1989. PMID: 2702641
-
Modeling growth kinetics and statistical distribution of oligometastases.Semin Radiat Oncol. 2006 Apr;16(2):111-9. doi: 10.1016/j.semradonc.2005.12.006. Semin Radiat Oncol. 2006. PMID: 16564446 Review.
-
Tumor cell proliferation kinetics and tumor growth rate.Acta Oncol. 1989;28(1):113-21. doi: 10.3109/02841868909111193. Acta Oncol. 1989. PMID: 2650719 Review.
Cited by
-
Early postoperative chemotherapy following noncurative resection for patients with advanced gastric cancer.Br J Cancer. 1992 Mar;65(3):413-6. doi: 10.1038/bjc.1992.84. Br J Cancer. 1992. PMID: 1558796 Free PMC article. Clinical Trial.
-
Growth of metastases of the mouse adenocarcinoma EO 771: an allometric relationship between growth of the primary tumors and their metastases.Clin Exp Metastasis. 1990 Jul-Aug;8(4):329-43. doi: 10.1007/BF01810679. Clin Exp Metastasis. 1990. PMID: 2350919
-
The concept of immunochemosurgery in gastric cancer.World J Surg. 1987 Aug;11(4):465-72. doi: 10.1007/BF01655811. World J Surg. 1987. PMID: 3630191 Clinical Trial. No abstract available.
-
Long-term outcome of neoadjuvant therapy for locally advanced breast carcinoma: effective clinical downstaging allows breast preservation and predicts outstanding local control and survival.Ann Surg. 2002 Sep;236(3):295-302; discussion 302-3. doi: 10.1097/01.SLA.0000027526.67560.64. Ann Surg. 2002. PMID: 12192316 Free PMC article.
-
The impact of early adjuvant chemotherapy in rectal cancer.PLoS One. 2020 Jan 31;15(1):e0228060. doi: 10.1371/journal.pone.0228060. eCollection 2020. PLoS One. 2020. PMID: 32004327 Free PMC article.